Histoindex
Highly Engaged Employees
Business Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Teletech Park 20 Science Park Road #01-2...Phone Number
+65 67744990Website
www.histoindex.comRevenue
<$5 MillionIndustry
About Histoindex
Histoindex Org Chart
Is Histoindex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Histoindex has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Histoindex
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Histoindex had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Histoindex recently announced quarterly report
Product Launch: Get notified when Histoindex launches new products
Histoindex, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Histoindex is spiking on competitors!
Funding: Get notified immidiatlly once Histoindex has new funding data
Recommended Actions
Find VP level buyers at Histoindex
Find 3 more new buyers
Company Profile Activity
Activity Insights
Histoindex is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Histoindex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Histoindex.
Histoindex Tech Stack
A closer look at the technologies used by Histoindex
Most Recent Scoops
Histoindex News & Media
HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025
SINGAPORE, Oct. 14, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, is returning to The Liver Meeting® (TLM) 2025, hosted by the American Association for the Study of Liver Diseases (AASLD). The conference, which brings...HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment
SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation of...HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion
SINGAPORE, May 2, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next phase of expansion. OCBC, the longest established bank in Singapore and the second largest financial services group in Southeast Asia by assets, investing for the first tiA New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
SINGAPORE, March 18, 2025 /PRNewswire/ -- HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States. This marks a significant milestone for HistoIndex as the company enters clinical care for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH). "I am excited to see how our core expertise in clinical trial assessments
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Histoindex
Founded in 2010, HistoIndex pioneers in stain-free, fully automated imaging solutions for visualizing and quantifying fibrosis in biological tissues. By combining cutting-edge biophotonic technology with AI-based analysis, HistoIndex provides innovative tools to improve the assessment of fibrosis changes and drug efficacy. HistoIndex’s breakthrough... Read More